Email updates

Keep up to date with the latest news and content from Diagnostic Pathology and BioMed Central.

Open Access Short report

High RBM3 expression in prostate cancer independently predicts a reduced risk of biochemical recurrence and disease progression

Liv Jonsson*, Alexander Gaber, David Ulmert, Mathias Uhlén, Anders Bjartell and Karin Jirström

Diagnostic Pathology 2011, 6:91  doi:10.1186/1746-1596-6-91

Accesses  

  • Last 30 days: 81 accesses
  • Last 365 days: 797 accesses
  • All time: 2231 accesses

Cited by